This Solicitation opportunity from California was posted on August 7, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

25-26026 CalRx School Albuterol Access Initiative

Closed

0000036366State & Local

Submission Closed09/04/2025, 12:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 456110

New

SLED

Pharmaceutical ServicesSealed bids are being solicited to provide pharmaceutical services, including all necessary medications, for inmates at the Trumbull County Adult Justice Center in Ohio. Bids must be submitted to the Board of County Commissioners at the County Administration Building, 160 High St N.W., Warren, Ohio, no later than 11:00 a.m. on July 24, 2026, and will be publicly opened on the same day. The solicitation is issued under reference number RFP-26-26-0-2026/lb and was posted on July 2, 2026, with all proposals required to meet the specified deadline. Services are to be performed within Trumbull County, Ohio, and the procurement is managed by the county’s public safety and corrections agency under state-level governance. Bidders must ensure compliance with all requirements for delivering and managing pharmaceuticals in a correctional setting, though specific terms such as contract duration, pricing structure, or clinical protocols are not detailed here.

POSTED

DEADLINE

ON-SITE PHARMACY SERVICES AND PHARMACY SUBLEASEBurke Center is soliciting proposals for on-site pharmacy services and a pharmacy sublease to serve individuals under its care and selected staff across its eleven-county service area, with a primary location in Lufkin, Texas. The contractor will operate an in-house pharmacy to dispense medications and provide related services not only at the main facility but also at off-site Burke locations, ensuring continuous pharmaceutical support for participants and employees. This RFP follows Burke’s FY25 expenditure of approximately $29,000 for prescriptions previously handled as a direct purchase obligation, and the agency now seeks a long-term partner to assume responsibility for comprehensive pharmacy operations over a two-year period. The sublease component involves contracting for a dedicated space within the Lufkin facility to house the pharmacy operations, and the selected vendor must be capable of managing all aspects of medication distribution, compliance, inventory, and patient support under state and federal regulations. All responses are due by July 29, 2026, and inquiries should be directed to Shelly Zmijowski or Pamela Caldwell via provided contact information. This solicitation, issued under RFP104PHSL, is open to qualified vendors seeking to deliver integrated pharmacy solutions that improve efficiency, reduce costs, and enhance care outcomes for Burke’s population over the next two fiscal years.

POSTED

DEADLINE

Sources Sought - Pharmacy Reverse Distribution Service for the Woodrow Wilson Keeble Memorial Healthcare Center, Sisseton, SD.The Indian Health Service is seeking market information for pharmacy reverse distribution services at the Woodrow Wilson Keeble Memorial Health Care Center in Sisseton, South Dakota, under Sources Sought Notice IHS-SS-26-1526527. This effort is part of a planned acquisition to secure a firm fixed-price, non-personal service contract for a 12-month period, with the primary objective of managing the return and destruction of expired medications. The required services include providing prepaid self-service shipping labels for all expired drug shipments at no cost to the government, ensuring pharmacy staff receive accurate packaging instructions, and arranging pickup of shipping containers within 10 business days of request. The contractor must also supply detailed documentation identifying all controlled substances within 60 days of receipt, accept non-returnable and hazardous drugs for destruction without additional charges, and apply credit to the pharmacy prime vendor account within 120 days. An annual performance summary report is required, and all services must be performed in compliance with strict quality metrics, including 100% fulfillment of label provision, documentation timeliness, and destruction acceptance, with 95% of pickups and credit applications occurring on schedule. The acquisition is designated as a Buy Indian Set-Aside under NAICS code 456110, prioritizing Indian Small Business Economic Enterprises and other small businesses. Respondents must submit a capability statement not exceeding 10 single-spaced pages in 12-point font, including their UEI number, organizational details, business certification status, past performance examples, and their assessment of the requirement’s feasibility and potential innovative approaches. All submissions must be emailed to the designated point of contact by July 10, 2026, and must not contain classified or sensitive information. Payment will be processed exclusively through the Invoice Processing Platform (IPP), mandatory under OMB and HHSAR requirements, and contractors are fully responsible for all associated costs, including labor, travel, lodging, fringe benefits, and federal, state, and local taxes. Though this notice serves solely for market research and does not obligate the government to award a contract, responses will inform the development of a future solicitation. The government retains the right to accept or reject services based on performance and will evaluate contractors based on their ability to meet all specified deliverables and quality standards.

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Mail-Order Pharmacy Fulfillment ServicesThe contract requires the operation of a mail-order pharmacy to fulfill 90-day prescription orders with direct-to-member delivery, encompassing all aspects of packaging, labeling, and shipping. The services must be performed in compliance with regulatory and quality standards to ensure timely and accurate dispensing of medications to members. The place of performance is designated as Boston, Massachusetts, with the work expected to be managed under the oversight of the Group Insurance Commission, which is part of the Massachusetts state government. The solicitation is classified as a subcontract under NAICS code 456110 for mail-order pharmacies, with a response deadline of August 5, 2026, and was posted on May 29, 2026. The contract does not specify any set-aside provisions or eligible entity types, indicating an open competition for qualified vendors. All responsibilities center on end-to-end fulfillment of prescriptions delivered directly to members, requiring robust logistics, secure handling of pharmaceuticals, and adherence to state and federal pharmaceutical distribution laws.

GIC00 - Group Insurance Commission

POSTED

DEADLINE

CVS Pharmacy - additional testing fundingThe Centers for Disease Control and Prevention is forecasting funding for additional testing services through CVS Pharmacy under NAICS code 456110, which pertains to retail pharmacies. This initiative aims to expand diagnostic testing capacity, potentially supporting public health efforts such as disease surveillance, outbreak response, or community health screenings. The opportunity is listed as a forecast with no solicitation number yet assigned, indicating it is a preliminary notice rather than an active procurement. The point of contact for program inquiries is Holly Nickle, reachable via email at ubf6@cdc.gov, while the contracting officer position is currently listed as to be determined. The place of performance and specific location details have not been identified, suggesting the scope may be national or flexible based on operational needs. No set-aside designation has been specified, meaning the opportunity is open to all eligible contractors. The forecast was posted on May 25, 2026, and interested parties can find more information through the provided UI link.

Centers For Disease Control And Prevention

POSTED

about 1 month ago

DEADLINE

N/A

General Info

Agency

California → Health Care Access and InformaView Agency

NAICS

456110 - Pharmacies and Drug Retailers View NAICS

Place of Performance

CA, USA

Set-Aside

NONE

Documents

(2)

RFI for CalRx School Albuterol Access Initiative under California Drug Affordability Act

PDF•8 pages•sources-sought

RFI_25-26026_Q_A.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedAug 7

Solicitation

Response DeadlineSep 4

Deadline has passed

Submission Closed

09/04/2025, 12:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyCalifornia → Health Care Access and Informa

Contacts1 person available

OfficeN/A

Organization / Agency

California → Health Care Access and Informa

View Agency Profile

Office AddressN/A

Contacts

Chantelle Parr

contact@example.gov

Full Description

The State of California, through the California Department of Health Care Access and Information (HCAI), is requesting information concerning potential partnerships in support of the CalRx School Albuterol Access Initiative under the California Affordable Drug Manufacturing Act of 2020. This statewide initiative aims to create a centralized ordering system and provide an emergency stock supply of no fewer than two (2) 90 mcg/actuation albuterol sulfate inhalation aerosol metered-dose inhalers (MDIs) and twenty-five (25) single-use disposable holding chambers/spacers to each of California¿s 10,000 transitional kindergarten (TK) through grade 12 schools annually at a low price, inclusive of shipping costs.
This Request for Information (RFI) seeks to gather relevant information from potential partners to evaluate their products, practices, and capabilities for manufacturing and/or distributing generic albuterol 90 mcg/actuation MDIs and single-use disposable holding chambers/spacers to TK¿12 schools, school districts, county offices of education, and/or charter schools in California. Responses will help HCAI assess potential partnerships and develop a procurement process for schools.
HCAI is also investigating affordability and accessibility of albuterol MDIs in the broader market and seeks to gather relevant information from potential partners who are interested in manufacturing and/or distributing a generic albuterol 90 mcg/actuation MDI under the CalRx label for all Californians through typical pharmaceutical pathways such as retail and mail-order pharmacies. In this arrangement, the albuterol MDI would be manufactured and/or distributed on behalf of CalRx with CalRx branding.
Respondents should read this RFI document thoroughly and adhere to the response submission guidelines.